PLX · Forms 3, 4, 5
Insider trades at Protalix BioTherapeutics, Inc.
No open-market insider buys or sells at Protalix BioTherapeutics, Inc. in the last 90 days; 9 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Protalix BioTherapeutics, Inc. (PLX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aharon Schwartz | Director | Options or other derivatives | Form 4 | ||||
| Yaron Naos | Sr. VP & COO | Options or other derivatives | Form 4 | ||||
| Christian Elze | Director | Options or other derivatives | Form 4 | ||||
| Gwen A Melincoff | Director | Options or other derivatives | Form 4 | ||||
| Pol F Boudes | Director | Options or other derivatives | Form 4 | ||||
| Dror Bashan | PRESIDENT AND CEO | Options or other derivatives | Form 4 | ||||
| Amos Bar-Shalev | Director | Options or other derivatives | Form 4 | ||||
| Zvi Shmuel Ben | Director | Options or other derivatives | Form 4 | ||||
| Eliot Forster | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.